7752
T. Ohshima et al. / Tetrahedron 60 (2004) 7743–7754
column chromatography (silica gel, EtOAc to 20% MeOH
in EtOAc) to give (S,S)-3p (7.74 g, 8.0 mmol, 89%) as a
yellow solid. Mp 132–135 8C; Rf¼0.35 (silica gel, 10%
MeOH in EtOAc); [a]D23¼263 (c 1.05, CDCl3); FT-IR
AgBF4 (428 mg, 2.2 mmol) was added to a solution of 3p
(913 mg, 1 mmol) in CH2Cl2 (5 mL). The mixture was
stirred at room temperature for 2 h, and filtrated to remove
the AgI. The solvent was evaporated and the residue was
purified by flash column chromatography (silica gel, 50–
100% EtOAc in hexane) to give 3ii (846 mg, 0.95 mmol,
95%). Mp 171–173.5 8C; Rf¼0.72 (silica gel, EtOAc);
[a]2D3¼233.2 (c 1.11, CHCl3); FT-IR (KBr) nmax 2972,
(KBr) nmax 3448, 2961, 1611, 1464, 1182, 1027, 841 cm21
;
1H NMR (500 MHz, CDCl3) d 7.66 (d, J¼8.5 Hz, 2H;
Ar-H), 7.60 (d, J¼8.5 Hz, 2H; Ar-H), 7.54 (d, J¼8.5 Hz,
2H; Ar-H), 7.47 (d, J¼8.5 Hz, 2H; Ar-H), 6.93 (d,
J¼8.5 Hz, 6H; Ar-H), 6.89 (d, J¼8.5 Hz, 2H; Ar-H), 5.94
(m, 1H; OCH), 5.49 (d, J¼13.0 Hz, 1H; NCHaHbAr), 5.40
(d, J¼12.5 Hz, 1H; NCHcHdAr), 5.18 (d, J¼14.5 Hz, 1H;
OCHCHaHbN), 5.06 (d, J¼12.5 Hz, 1H; NCHeHfAr), 4.78
(d, J¼12.5 Hz, 1H; NCHgHhAr), 4.76 (d, J¼12.5 Hz, 1H;
OCHCHcHdN), 4.71 (d, J¼13.0 Hz, 1H; NCHaHbAr), 4.67
(d, J¼13.0 Hz, 1H; NCHeHfAr) 4.64 (d, J¼12.5 Hz, 1H;
NCHgHhAr), 4.56 (m, 1H; OCH), 4.31 (d, J¼12.5 Hz, 1H;
NCHcHdAr), 4.10 (dd, J¼12.5 Hz, 10.0 Hz, 1H; OCHCHc-
HdN), 3.80 (s, 6H; OCH3), 3.78 (s, 3H; OCH3), 3.73 (s, 3H;
OCH3), 3.49 (dd, J¼14.5, 6.0 Hz, 1H; OCHCHaHbN), 2.94
(s, 3H; NCH3), 2.91 (s, 3H, NCH3), 1.83 (s, 3H; Me), 0.96
(s, 9H; t-Bu); 13C NMR (125 MHz, CDCl3) d 161.7, 161.6,
135.5, 135.4, 135.2, and 135.1 (Ar), 119.3 (t-BuCMe),
118,7, 118.6, 118.4, 118.0, 115.6, 115.0, and 114.9 (Ar),
74.6 (OCH), 73.2 (OCH), 66.2, 65.8, 65.2, and 65.0 (4 C;
ArCH2N), 62.1 (OCHCH2Nþ), 60.6 (OCHCH2Nþ), 55.8
(OCH3), 47.6 (NþCH3), 46.1 (NþCH3), 39.2 (C(CH3)3),
25.7 (C(CH3)3), 22.7 (Me); MS [ESI(þ)] m/z 989
[MþNaþ], 839 [M2I2], 591 [M22I2-CH2Ar]. Anal.
calcd for C44H62I2N2O7 (MþH2O): C 53.66, H 6.35, N
2.84. Found: C 53.66, H 6.40, N 3.04.
1
2841, 1613, 1518, 1468, 1029, 843, 762 cm21; H NMR
(500 MHz, CDCl3) d 7.47–7.37 (m, 8H; Ar-H), 6.96 (d,
J¼9.0 Hz, 2H; Ar), 6.95 (d, J¼9.0 Hz, 2H; Ar), 6.90 (d,
J¼8.5 Hz, 4H; Ar), 4.88 (m, 1H; OCH), 4.76 (d, J¼14.0 Hz,
1H; NCHaHbAr), 4.73 (d, J¼14.0 Hz, 1H; NCHcHdAr),
4.58 (d, J¼13.0 Hz, 2H; NCHeHfAr, NCHgHhAr), 4.41–
4.32 (m, 4H; NCHaHbAr, NCHcHdAr, NCHeHfAr, NCHg-
HhAr), 4.30 (m, 1H; OCH), 3.82 (s, 6H; OMe), 3.80 (s, 3H;
OMe), 3.78 (s, 3H; OMe), 3.76 (m, 2H; OCHCH2N), 3.63
(m, 2H; OCHCH2N), 2.81 (s, 6H; NMe), 1.49 (s, 3H; Me),
0.90 (s, 9H; t-Bu); 13C NMR (126 MHz, CDCl3) d 161.7,
161.6, 135.0, 134.9, 134.8, and 134.7 (Ar), 119.0
(t-BuCMe), 118.4, 118.3, 118.2, 118.0, 115.1, 115.0,
114.94, and 114.91 (Ar), 74.0 (OCH), 72.6 (OCH), 67.6,
67.2, 66.6, and 66.2 (4 C; ArCH2N), 62.3(CHCH2N), 61.6
(CHCH2N), 55.5 (OCH3), 46.5 (NCH3), 45.6 (NCH3), 38.8
(C(CH3)3), 25.3 (C(CH3)3), 20.6 (Me); MS [ESI(þ)] m/z
909 [MþNaþ], 799 [M2BF24 ]; HR-MS [FAB (þ)] calcd
for C44H60F4N2O6Bþ (M2BF24 ): 799.4475. Found:
799.4469.
4.2.6. (4S,5S)-N,N0-Dimethyl-N,N,N0,N0-tetrakis[(4-
methylphenyl)methyl]-2,2-dipropyl-1,3-dioxolane-4,5-
dimethanammonium bistetrafuluoroborate ((S,S)-3dd).
A white solid. Mp 201–204 8C; Rf¼0.68 (silica gel,
EtOAc); [a]2D2¼232.4 (c 0.98, CHCl3); FT-IR (KBr) nmax
4.2.4. (4S,5S)-N,N0-Dimethyl-N,N,N0,N0-tetrakis[(4-
methylphenyl)methyl]-2,2-dipropyl-1,3-dioxolane-4,5-
dimethanammonium diiodide ((S,S)-3t). A yellow pale
solid. Mp 112–115 8C; Rf¼0.41 (silica gel, EtOAc);
[a]2D2¼256.3 (c 1.02, CHCl3); FT-IR (KBr) nmax 2958,
1614, 1464, 1105, 805 cm21; 1H NMR (500 MHz, CDCl3) d
7.56 (d, J¼7.5 Hz, 4H; Ar-H), 7.49 (d, J¼7.5 Hz, 4H; Ar-H),
7.24–7.28 (m, 8H), 5.29 (m, 2H; OCH), 5.23 (d, J¼12.5 Hz,
2H; ArCH2N), 5.18 (d, J¼12.5 Hz, 2H; ArCH2N), 5.09 (d,
J¼14.0 Hz, 2H, OCHCH2N), 4.73 (d, J¼12.5 Hz, 2H;
ArCH2N), 4.40 (d, J¼12.5 Hz, 2H; ArCH2N), 3.85 (m, 2H;
OCHCH2N), 2.97 (s, 6H, NCH3), 2.39 (s, 6H; Ar-CH3), 2.35
(s, 6H; Ar-CH3), 1.89 (m, 2H, Pr), 1.81 (m, 2H; Pr), 1.33 (m,
4H; Pr), 0.95 (t, J¼7.0 Hz, 6H; Pr); 13C NMR (125 MHz,
CDCl3) d 141.2 and 141.1 (Ar), 133.4 and 133.2 (Ar), 130.1
and130.0(Ar), 123.3and123.1(Ar), 116.7(PrCPr), 73.0(2C;
OCH), 66.0 (2 C; ArCH2N), 65.1 (2 C; ArCH2N), 61.4 (2 C;
CHCH2N), 46.4 (NCH3), 39.7 (Pr), 21.2 (Ar-CH3), 17.5 (Pr),
14.0 (Pr); MS [ESI(þ)] m/z 789 [M2I2], 557 [M22I2-
CH2Ar]. Anal. calcd for C45H64N2O3 (MþH2O): C 57.82, H
6.90, N 3.00. Found: C 57.77, H 6.86, N 3.04.
1
2963, 1617, 1475, 1074, 790 cm21; H NMR (500 MHz,
CDCl3) d 7.41 (d, J¼8.0 Hz, 4H; Ar-H), 7.36 (d, J¼8.0 Hz,
4H; Ar-H), 7.28–7.23 (m, 8H; Ar-H), 4.80 (d, J¼13.0 Hz,
2H; ArCH2N), 4.77 (d, J¼12.0 Hz, 2H; ArCH2N), 4.70 (d,
J¼7.0 Hz, 2H; OCH), 4.40 (d, J¼12.0 Hz, 2H; ArCH2N),
4.30 (d, J¼13.0 Hz, 2H; ArCH2N), 3.96 (d, J¼13.5 Hz, 2H;
OCHCH2N), 3.78 (dd, J¼13.5, 8.0 Hz, 2H; OCHCH2N),
2.40 (s, 6H; Ar-CH3), 2.83 (s, 6H; NCH3), 2.37 (s, 6H;
Ar-CH3), 1.70 (m, 4H, Pr), 1.27 (m, 4H; Pr), 0.91 (t,
J¼7.5 Hz, 6H; Pr); 13C NMR (125 MHz, CDCl3) d 141.5,
130.3, 123.5, and 123.3 (Ar), 117.0 (PrCPr), 73.0 (OCH),
67.5 (2C; ArCH2N), 66.6 (2C; ArCH2N), 62.5 (OCHCH2N),
46.1 (NCH3), 14.2 (Pr), 39.5 (Pr), 21.4 (Ar-CH3), 17.6 (Pr);
MS [ESI(þ)] m/z 749 [M2BF24 ], 557 [M22BF42-CH2Ar].
Anal. calcd for C45H62B2F8N2O2: C 64.60, H 7.47, N 3.35.
Found: C 64.49, H 7.37, N 3.31.
4.3. General procedure for the catalytic asymmetric
phase-transfer alkylation using TaDiAS 3p under
optimized conditions
4.2.5. Synthesis of (4S,5S)-2-tert-butyl-N,N,N0,N0-tetra-
kis[(4-methoxyphenyl)methyl]-N,N0-2-trimethyl-1,3-
dioxolane-4,5-dimethanammonium bistetrafluoroborate
((S,S)-3ii). Trimethyloxonium tetrafluoroborate (4.44 g,
30 mmol) was added to a solution of 8p (6.32 g, 10 mmol)
in CH2Cl2 (100 mL) at room temperature. The mixture was
stirred for 6 h and concentrated. The residue was
recrystallized from ethyl acetate and hexane to give 3ii as
a white solid (7.26 g, 8.7 mmol, 87%). Alternatively, 3ii can
be synthesized from 3p using the following procedure.
A solution of 4-(triisopropylsilanyloxy)benzyl bromide
(approximately 0.2 M in toluene, 7.0 mL, 3.5 mmol,
5.0 equiv.) was added to a mixture of N-(diphenyl-
methylene)glycine tert-butyl ester (1) (207 mg,
0.70 mmol) and phase-transfer catalyst (S,S)-TaDiAS 3p
(67 mg, 0.070 mmol, 10 mol%) in CH2Cl2 (3.0 mL, total
0.07 M) at 270 8C. Finally, CsOH·H2O (1.18 g, 7.0 mmol,
10 equiv.) was added directly to the reaction mixture at the